Trials / Completed
CompletedNCT04585412
Evaluate Bioequivalence of Palonosetron (0.25mg/5mL)
A Randomized, Single-dose, Two-way Crossover Study to Evaluate Bioequivalence of Two Formulations of Palonosetron After Intravenous Administration of Palonosetron in Healthy Volunteers Under Fasting Conditions
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Yung Shin Pharm. Ind. Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
A randomized, single-dose, two-way crossover study to evaluate bioequivalence of two formulations of palonosetron after intravenous administration of palonosetron in healthy volunteers under fasting conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Palonosetron | Pharmacokinetic study under fasting conditions |
Timeline
- Start date
- 2020-08-17
- Primary completion
- 2020-10-24
- Completion
- 2020-12-31
- First posted
- 2020-10-14
- Last updated
- 2021-08-04
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT04585412. Inclusion in this directory is not an endorsement.